HAVCR2 and sarcoma: In our study, we found that TIM-3 expression was higher in the high m6A score group than in the low m6A score group, and based on the findings of the existing studies [31, 32], we again confirmed that the prognosis of patients with sarcoma in the high m6A score group was worse than that in the low m6A score group.